Nutromics

Last week we welcomed Saimon M. Silva and his Chemistry Capstone students at La Trobe University onsite! Marsilea Booth, Johanna Wordsworth, and Kyle May took the group through how Nutromics' DNA-based sensors work and how our different teams collaborate to build them from scratch. Thank you to the students for their curiosity and interest! We love opportunities to share the work we're doing with future STEM legends.

Our Head of IP Brendan C. will be speaking at IAM & WTR Live: Australasia IP Forum 2026! This conference will explore the most critical challenges and emerging opportunities in asset management, from AI-powered practice and portfolio commercialization to geopolitical headwinds, cross-border enforcement, and the strategies defining tomorrow's patent and trademark landscape. Register here 👉 https://lnkd.in/g72PExkr

Rob Batchelor, Distinguished Scientist at Nutromics is attending IEEE BioSensors 2026 over the next few days. Rob is also one of the two plenary speakers at this year's conference. With over 25 years in biosensor R&D, multiple patents, and over 50 products brought to market, Rob brings rare insights on what it takes to translate and commercialize innovative biosening technologies. If you're at the conference, come say hi!

We started this week with some very exciting news: we're finalists in Startup Daily's 2026 Best in Tech Awards. Stephanie Larson, Senior Operations Analyst, is a finalist for Startup Employee of the Year. As our team can attest, Stephanie is the one keeping everything moving while the rest of us have our heads down, so it is lovely to see her get recognized for her incredible work! Nutromics is also a finalist for the Most Innovative Startup award. There are some incredible companies building things across Australia and New Zealand, and being counted among them is not something we take lightly. Thank you to Startup Daily for shining a light on this part of the industry 🙌 Read more here: https://lnkd.in/gTq-UqSS

We were glad to partner with Monash University again this year for the Monash Innovation Guarantee - Postgraduate. As partners, our team set up challenges that involved real-world problems for the students to solve. They offered their time and mentorship to work through those challenges while providing an insight into life at Nutromics. Final presentations are this week, and we can't wait to see what the students come up with. Good luck to everyone taking part, and thank you for the energy and ideas you brought. Also, a huge thank you to Tom Millward and Keri Clarke for coordinating it all. You've been brilliant to work with 👏

Guess who’s back? Prof Kevin Plaxco! Fresh off being named a finalist in the 2026 UC Regents Innovation Awards, Kevin has landed just in time for some exciting projects we've got in the works.    Congratulations, and welcome back to Melbourne! 

Franciele de Matos Morawski is a Senior Scientist on our Sensors team at Nutromics. Refinement is at the core of her role. She takes our research forward and keeps our sensors performing better in the real world, chasing that last bit of precision every time. Here's a look at a day in her work, captured on film 📸

A recent independent review in ACS Sensors from a team at Vilnius University explored the question of “Why, after three decades and thousands of papers, are electrochemical DNA sensors still only in the lab?” The paper explores both the difficulties of DNA detection and the tools built along the way to enable it. The authors also mention that these tools have been critical to the emergence of aptamer-based sensing, which they identify as the most mature and commercially advanced redirection of the field. The authors identified the two companies commercializing aptamer-based sensing: one of which is Nutromics! In fact, our recent first-in-human publication in Nature Biotechnology was called out as landmark evidence that this redirection is real and material. Their closing question is a fair one: could continuous molecular monitoring earn broad clinical adoption alongside standard blood tests? That's the question our team is working to answer with a resounding YES! Read the review here 👉 https://lnkd.in/gGXitG4z Read our Nature Biotechnology paper 👉 https://lnkd.in/gzm-K2m8 American Chemical Society

Why is it that some medical innovations have seen widespread adoption despite known limitations, while other well-evidenced and effective innovations take decades to become clinical practice, if ever? Exploring this question further in an article for MedTech Spectrum, Robert McLeay, a doctor and former founder of DoseMe, elaborates on three factors that must be met for the acceptance and adoption of new innovations. Read the article here 👉 https://lnkd.in/gh6hWGwV

Research, discovery, and translation are, by nature, collaborative efforts. They require a coming together of varied minds to challenge ideas, experiment, and create something new. Dheeraj D'Souza shows us what that looks like in action, with a glimpse into his day as a Bioinformatics Scientist at Nutromics 📸